Emergent BioSolutions Inc. Form 4 (March 1, 2021)

Summary

This Emergent BioSolutions Inc. Form 4 for Havey Adam, an officer with the title EVP, Business Operations, reports transactions on 03/01/2021 under a Rule 10b5-1 trading plan adopted by Mr. Havey. The reporting person exercised 17,134 Employee Stock Options (Right to Buy) at $30.63 and sold 17,134 shares at a weighted average sale price of $99.62, in multiple transactions at prices ranging from $98.05 to $100.25. A second exercise of 20,145 options at $49.64 was followed by a sale of 20,145 shares at a weighted average of $99.02, within a range of $98.01 to $99.99. Shares owned directly were 38,190 after the sales, and the remarks show /s/ S. Scott Lieberman, Attorney-in-fact, dated 03/02/2021.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Havey Adam (Last) (First) (Middle) 400 PROFESSIONAL DR, SUITE 400 (Street) GAITHERSBURG MD 20879 (City) (State) (Zip) | Havey Adam | (Last) | (First) | (Middle) | 400 PROFESSIONAL DR, SUITE 400 | GAITHERSBURG | MD | 20879 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Emergent BioSolutions Inc. [ EBS ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) EVP, Business Operations | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | EVP, Business Operations
3. Date of Earliest Transaction
 (Month/Day/Year) 03/01/2021
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 03/01/2021 | M | 17,134 (1) | A | $ 30.63 | 55,324 | D
Common Stock | 03/01/2021 | S | 17,134 (1) | D | $ 99.62 (2) | 38,190 | D
Common Stock | 03/01/2021 | M | 20,145 (1) | A | $ 49.64 | 58,335 | D
Common Stock | 03/01/2021 | S | 20,145 (1) | D | $ 99.02 (3) | 38,190 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Employee Stock Options (Right to Buy) | $ 30.63 | 03/01/2021 | M (1) | 17,134 | (4) | 02/27/2024 | Common Stock | 17,134 | $ 99.62 (2) | 0 | D
Employee Stock Options (Right to Buy) | $ 49.64 | 03/01/2021 | M (1) | 20,145 | (4) | 02/26/2025 | Common Stock | 20,145 | $ 99.02 (3) | 0 | D
Explanation of Responses:
1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
2. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.05 to $100.25.
3. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.01 to $99.99.
4. Vests in three equal installments beginning on the day prior to the anniversary date of the grant.
Remarks:
/s/ S. Scott Lieberman, Attorney-in-fact | 03/02/2021
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_EBS_4_filed2021-03-03_0001367644-21-000049.xml

Size

19,944 bytes

SHA-256

cf99e1496d7bc74e87633103a193e47a795051de8bf9a3ff0a1d335f550e2f95

Our copy

SEC_EBS_4_filed2021-03-03_0001367644-21-000049.xml

Original

www.sec.gov